Related Experiment Video
Updated: Mar 15, 2026

13:36
Author Spotlight: Dendritic Cells Maturation Using Sialidases-Based Enzymatic Treatment of the Cell Surface
Published on: October 20, 2023
4.4K
Reduced immune response to polymeric micelles coating sialic acids
Masashi Ohmae1, Mei Kojima1, Kenta Mihara1
1Department of Material Chemistry, Graduate School of Engineering, Kyoto University, Kyoto daigaku-katsura, Nishikyo-ku, Kyoto 615-8510, Japan.
Bioorganic & Medicinal Chemistry Letters
|September 15, 2016
Summary
Sialic acid coatings on Lactosomes prevent rapid clearance from the bloodstream by reducing immune responses. These nanocarriers show potential for improved drug delivery by evading immune detection.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Immunology
Background:
- The accelerated blood clearance (ABC) phenomenon limits the efficacy of nanocarriers by causing rapid elimination from circulation.
- Polymeric micelles, such as poly(sarcosine)-block-poly(l-lactic acid) (Lactosome) based nanocarriers, are susceptible to the ABC phenomenon.
Purpose of the Study:
- To investigate the effect of sialic acid coatings on Lactosomes to prevent the ABC phenomenon.
- To develop sialic acid-presenting Lactosomes that target immunosuppressive receptors like Siglec-G and CD22.
Main Methods:
- Preparation of two types of sialic acid-presenting Lactosomes.
- Evaluation of the effect of sialic acid moieties on anti-poly(sarcosine) IgM production.
- Assessment of the interaction between sialic acid and immune cell receptors (Siglec-E) to suppress phagocytosis.
Main Results:
- Sialic acid-coated Lactosomes significantly diminished the ABC phenomenon.
- The reduction in ABC phenomenon was attributed to decreased anti-poly(sarcosine) IgM production.
- Sialic acid moieties demonstrated potential to interact with Siglec-E on immune cells, suppressing phagocytosis of opsonized nanocarriers.
Conclusions:
- Sialic acid coatings are effective in preventing the ABC phenomenon for poly(sarcosine)-based nanocarriers.
- Targeting Siglec-G and CD22 receptors with sialic acid-presenting Lactosomes enhances their circulation time.
- These findings suggest a promising strategy for improving the pharmacokinetic profiles of nanocarrier-based drug delivery systems.

